Evidence map›Paper›PMID 29401743›Full record

ReviewMedicines (Basel, Switzerland)2018

Current and Future Applications of Biomedical Engineering for Proteomic Profiling: Predictive Biomarkers in Neuro-Traumatology.

Mario Ganau, Nikolaos Syrmos, Marco Paris, Laura Ganau, Gianfranco K I Ligarotti, Ali Moghaddamjou, Salvatore Chibbaro, Andrea Soddu, Rossano Ambu, Lara Prisco

Open access · goldAbstract readReview
In one paragraph

Review in Medicines (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Reduction of Traumatic Brain Damage by Tspo Ligand Etifoxine.International journal of molecular sciences · 2019
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 5 countries.

Mario GanauDepartment of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, ON M5T 2S8, Canada. mario.ganau@alumni.harvard.edu.
Nikolaos SyrmosSchool of Medicine, Aristotle University of Thessaloniki, 54623 Thessaloniki, Greece. milanako76@yahoo.gr.
Marco ParisNational Hospital for Neurology and Neurosurgery, University College London, London WC1N 3BG, UK. marco.paris@uclh.nhs.uk.ORCID 0000-0003-0098-2633
Laura GanauSchool of Medicine, University of Cagliari, 09124 Cagliari, Italy. lolly26it@yahoo.it.
Gianfranco K I LigarottiFondazione IRCCS IstitutoNeurologico "Carlo Besta", 20133 Milano, Italy. gianfrancokiligarotti@gmail.com.
Ali MoghaddamjouDepartment of Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, ON M5T 2S8, Canada. alim937@hotmail.com.
Salvatore ChibbaroDivision of Neurosurgery, University of Strasbourg, 67000 Strasbourg, France. schibbaro@hotmail.com.
Andrea SodduBrain and Mind Institute, Physics & Astronomy Department, Western University, London, ON N6A 3K7, Canada. asoddu@uwo.ca.
Rossano AmbuSchool of Medicine, University of Cagliari, 09124 Cagliari, Italy. amburo@unica.it.
Lara PriscoJohn Radcliffe Hospital, Oxford University, Oxford OX3 9DU, UK. lara.prisco@ndcn.ox.ac.uk.
University of Cagliari · ITAristotle University of Thessaloniki · GRFondazione IRCCS Istituto Neurologico Carlo Besta · ITJohn Radcliffe Hospital · GBNational Hospital for Neurology and Neurosurgery · GBUniversité de Strasbourg · FRUniversity of Toronto · CAWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This systematic review aims to summarize the impact of nanotechnology and biomedical engineering in defining clinically meaningful predictive biomarkers in patients with traumatic brain injury (TBI), a critical worldwide health problem with an estimated 10 billion people affected annually worldwide. Data were collected through a review of the existing English literature performed on Scopus, MEDLINE, MEDLINE in Process, EMBASE, and/or Cochrane Central Register of Controlled Trials. Only experimental articles revolving around the management of TBI, in which the role of new devices based on innovative discoveries coming from the field of nanotechnology and biomedical engineering were highlighted, have been included and analyzed in this study. Based on theresults gathered from this research on innovative methods for genomics, epigenomics, and proteomics, their future application in this field seems promising. Despite the outstanding technical challenges of identifying reliable biosignatures for TBI and the mixed nature of studies herein described (single cells proteomics, biofilms, sensors, etc.), the clinical implementation of those discoveries will allow us to gain confidence in the use of advanced neuromonitoring modalities with a potential dramatic improvement in the management of those patients.

Indexed as

biomarkersmass spectroscopymicroRNAproteomicstraumatic brain injury

Identifiers

PMID29401743
PMCPMC5874584
OpenAlexW2794010965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.